Metsera
Pfizer’s $10 Billion Gambit: Winning the War for Metsera and the Future of Weight Loss
Pfizer outmaneuvered rival Novo Nordisk in a $10bn bidding war for weight-loss startup Metsera, a strategic move to combat its looming patent cliff.
Pharma’s High-Stakes Gamble: Inside the Pfizer vs. Novo Bidding War for a Weight-Loss Unicorn
A fierce bidding war erupts between Pfizer and Novo Nordisk for biotech firm Metsera, signaling a high-stakes battle for the future of the obesity drug market.